Invasive fungal infections after Bruton tyrosine kinase inhibitor treatment: a systematic review and meta-analysis. [PDF]
Srisurapanont K +10 more
europepmc +1 more source
BTKi orelabrutinib improved the outcome of newly-diagnosed PCNS-LBCL by alleviating MyD88<sup>L265P</sup>-induced PIM1 stability. [PDF]
Yuan Y +26 more
europepmc +1 more source
Advances in first-line treatment for primary central nervous system lymphoma: highlights from the 2025 ASH annual meeting. [PDF]
Wei R, Yang S.
europepmc +1 more source
Cardiac safety profiles of first-generation vs second-generation BTK inhibitors: a meta-analysis. [PDF]
Mushtaq A +10 more
europepmc +1 more source
The diagnostic journey of a young adult with recurrent infections and progressive dyspnoea. [PDF]
Venugopal V +5 more
europepmc +1 more source
Visualization of a Bruton's Tyrosine Kinase Inhibitor Using Fluorescence and Raman Microscopy. [PDF]
Merchant AS +3 more
europepmc +1 more source
Real-world efficacy of Bruton tyrosine kinase inhibitor based maintenance therapy in diffuse large B-cell lymphoma: a multicenter retrospective cohort study with external historical control. [PDF]
Lyu LW +8 more
europepmc +1 more source
A single-center retrospective study suggests a potential benefit of BTK inhibitor-based therapy in patients with histologic transformation of Waldenström macroglobulinemia. [PDF]
Xia Y +10 more
europepmc +1 more source
Epidemiology, treatment patterns, and survival outcomes of patients with mantle cell lymphoma in Germany: a retrospective analysis of administrative claims data. [PDF]
Friedel H +8 more
europepmc +1 more source
Atypical X-linked agammaglobulinemia diagnosed in adulthood with arthritis caused by a hypomorphic BTK splice-site variant: a case report and literature review. [PDF]
Takayama A +7 more
europepmc +1 more source

